Nondosage-dependent valproic acid-induced hyperammonemia and coma
Gaskins, J.D.; Holt, R.J.; Postelnick, M.
Clinical Pharmacy 3(3): 313-316
1984
ISSN/ISBN: 0278-2677 PMID: 6428801 Document Number: 225489
Document emailed within 1 workday
Related Documents
Patel, N.; Landry, K.B.; Fargason, R.E.; Birur, B. 2017: Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report Psychopharmacology Bulletin 47(1): 40-44Neyns, B.; Hoorens, A.; Stupp, R. 2008: Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide Acta Neurologica Belgica 108(4): 131-134
Sobaniec, W.; Rudziński, P.; Jankowicz, E.; Sobaniec-Lotowska, M.; Kułak, W. 1989: Cardiazol-induced seizures and the concentration of lipid peroxides in the brain of rats under the influence of valproic acid and vitamin e Neuropatologia Polska 27(2): 229-236
Pinto, A.; Abraham, N.G.; Mullane, K.M. 1987: Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway Journal of Pharmacology and Experimental Therapeutics 240(3): 856-863
Porubek, D.J.; Grillo, M.P.; Baillie, T.A. 1989: The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(2): 123-130
Champel, V.; Radal, M.; Moulin-Vallez, M.; Jonville-Béra, A.P.; Autret-Leca, E. 1999: Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy Revue Neurologique (Paris) 155(3): 220-224
Zaret, B.S.; Marini, A.M. 1985: Standardization in VPA-induced hyperammonemia Neurology 35(1): 136-137
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Pappas, S.C.; Ferenci, P.; Schafer, D.F.; Jones, E.A. 1984: Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins Gastroenterology 86(3): 546-551
Kohda, Y. 1995: Valproic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 918-920
Klotz, U. 1977: Pharmacokinetic studies with valproic acid in man Arzneimittel-Forschung 27(5): 1085-1088
Waring, E.W.; Dewan, V.K.; Cohen, D.; Grewal, R. 1999: Risperidone as an adjunct to valproic acid Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(2): 189
Borchert, H.H.; Schuster, S.; Pfeifer, S. 1980: Metabolic interaction of valproic acid Die Pharmazie 34(5-6): 313-314
Gedan, A.; Kleemann, V.; Pfeifer, S. 1984: Hydrolysis of valproamide to valproic acid Die Pharmazie 39(12): 865
Löscher, W. 1981: Anticonvulsant activity of metabolites of valproic acid Archives Internationales de Pharmacodynamie et de Therapie 249(1): 158-163
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
Bruni, J.; Wilder, B.J.; Willmore, L.J.; Barbour, B. 1979: Valproic acid and plasma levels of phenytoin Neurology 29(6): 904-905
Michaelis, M.; Doerr, H.W.; Cinatl, J. 2007: Valproic acid as anti-cancer drug Current Pharmaceutical Design 13(33): 3378-3393
Tonnelier, J.M.; Mocquard, Y.; Broch, C.; Vandhuick, O.; Goas, P.; Goas, J.Y. 2001: Febrile pleuropericarditis during valproic acid treatment Presse Medicale 30(2): 62-63
Vajda, F.J. 1983: Valproic acid in the treatment of status epilepticus Advances in Neurology 34: 519-529